PDF icon Download PDF
Open Access
CC BY-NC-ND 4.0 · Arq Neuropsiquiatr 2020; 78(01): 39-43
DOI: 10.1590/0004-282X20190150
Article

Mechanical thrombectomy for reperfusion of acute ischemic stroke in a Stroke Unit in Argentina

Trombectomía mecánica para la reperfusión en el accidente cerebrovascular agudo en una Unidad Cerebrovascular de Argentina
Matías ALET 
1   Centro Integral de Neurología Vascular, FLENI, Buenos Aires, Argentina.
,
Federico Rodríguez LUCCI 
1   Centro Integral de Neurología Vascular, FLENI, Buenos Aires, Argentina.
,
Sebastián AMERISO 
1   Centro Integral de Neurología Vascular, FLENI, Buenos Aires, Argentina.
› Author Affiliations
› Further Information
Also available ateRef
  Permissions and Reprints
Preview

Abstract

Stroke is an important cause of morbidity and mortality worldwide. Reperfusion therapy with intravenous tissue plasminogen activator (IV-tPA) was first implemented in 1996. More recently, endovascular reperfusion with mechanical thrombectomy (MT) demonstrated a robust beneficial effect, extending the 4.5 h time window. In our country, there are difficulties to achieve the implementation of both procedures. Objective: Our purpose is to report the early experience of a Comprehensive Stroke Center in the use of MT for acute stroke. Methods: Analysis of consecutive patients from January 2015 to September 2018, who received reperfusion treatment with MT. Demographic data, treatment times, previous use of IV-tPA, site of obstruction, recanalization, outcomes and disability after stroke were assessed. Results: We admitted 891 patients with acute ischemic stroke during this period. Ninety-seven received IV-tPA (11%) and 27 were treated with MT (3%). In the MT group, mean age was 66.0±14.5 years. Median NIHSS before MT was 20 (range:14‒24). The most prevalent etiology was cardioembolic stroke (52%). Prior to MT, 16 of 27 patients (59%) received IV-tPA. Previous tPA treatment did not affect onset to recanalization time or door-to-puncture time. For MT, door-to-puncture time was 104±50 minutes and onset to recanalization was 289±153 minutes. Successful recanalization (mTICI grade 2b/3) was achieved in 21 patients (78%). At three-month follow-up, the median NIHSS was 5 (range:4‒15) and mRS was 0‒2 in 37%, and ≥3 in 63%. Conclusions: With adequate logistics and strict selection criteria, MT can be implemented in our population with results like those reported in large clinical trials.

Resumen

El accidente cerebrovascular isquémico (ACVi) es una importante causa de morbi-mortalidad a nivel mundial. La reperfusión con trombólisis endovenosa es utilizada desde 1996. Más recientemente, la reperfusión con trombectomía mecánica (TM) ha demostrado un beneficio consistente extendiendo la ventana terapéutica. En nuestro país existen dificultades para que su implementación sea una práctica habitual. Objetivo: Reportamos la experiencia de un Centro Integral de Neurología Vascular en el uso de TM como tratamiento del ACVi agudo. Métodos: Análisis retrospectivo de pacientes consecutivos desde enero 2015 a septiembre 2018, que recibieron reperfusión con TM. Se registraron datos demográficos, tiempos de tratamiento, uso de rtPA, sitio de obstrucción, recanalización, severidad del evento y discapacidad. Resultados: Se evaluaron 891 pacientes con ACVi en este periodo. 97 recibieron rtPA (11%) y 27 recibieron TM (3%). En el grupo TM, la edad promedio fue 66 años (±14.5). Mediana de NIHSS previo a TM: 20 (RIC 14‒24). La etiología más frecuente fue cardioembolia (52%). Previo a TM, 16 pacientes (59%) recibieron rtPA endovenoso. No hallamos efecto del rtPA en tiempo de recanalización por TM o tiempo puerta-punción. Para la TM, el tiempo puerta-punción fue 104±50 minutos y el tiempo entre inicio de síntomas-recanalización fue 289±153 minutos. En 21 pacientes (78%) se logró recanalización exitosa (TICI 2B/3). En el seguimiento a tres meses, el mRS fue 0‒2 en el 37% y ≥3 en el 63%. Conclusión: Una logística adecuada y un estricto criterio de selección ha posibilitado el uso de TM en nuestra población, obteniendo resultados similares a aquellos reportados en los estudios clínicos publicados.

Keywords:

acute stroke - Argentina - mechanical thrombectomy - systemic thrombolysis

Palabras clave:

accidente cerebrovascular - Argentina - trombectomía mecánica - trombólisis endovenosa


Publication History

Received: 23 July 2019

Accepted: 12 September 2019

Article published online:
13 June 2023

© 2020. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • References

  • 1 Feigin VL, Norrving B, Mensah GA. Global Burden of Stroke. Circ Res. 2017 Feb;120(3):439-48. https://doi.org/10.1161/CIRCRESAHA.116.308413
  • 2 Natalidad y mortalidad. Síntesis estadística. Dirección de estadísticas e información en Salud. Ministerio de Salud de la Nación. Available from: http://www.deis.msal.gov.ar/wp-content/uploads/2016/05/Sintesis-estadistica-Nro1.pdf
  • 3 Gómez-Schneider MM, Pujol-Lereis VA, Dossi D, Hawkes MA, Alet M, Rodriguez-Lucci F, et al. Prevalence of stroke in Argentina: A population-based Epidemiological Study (EstEPA). Stroke. 2018 Jan;49(Supl. 1):AWP196. https://doi.org/10.1161/str.49.suppl_1.WP196
  • 4 Dossi D, Pujol-Lereis V, Gómez-Schneider M, Gonzalez G, Hawkes MA, Rodriguez Lucci F, et al. Stroke Mortality in Argentina. A population-based Epidemiological Study, EstEPA. Stroke. 2018;49(Supl. 1):ATP197. https://doi.org/10.1161/str.49.suppl_1.TP197
  • 5 The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995 Dec;333(24):1581-8. https://doi.org/10.1056/NEJM199512143332401
  • 6 Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015 Mar;372:1019-30. https://doi.org/10.1056/NEJMoa1414905
  • 7 Berkhemer O, Fransen P, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015 Jan;372:11-20. https://doi.org/10.1056/NEJMoa1411587
  • 8 Campbell BCV, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, el at. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015 Mar;372:1009-18. https://doi.org/10.1056/NEJMoa1414792
  • 9 Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015 Jun;372(24):2285-95. https://doi.org/10.1056/NEJMoa1415061
  • 10 Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med Jun. 2015;372:2296-306. https://doi.org/10.1056/NEJMoa1503780
  • 11 Nogueira R, Jadhav A, Haussen D, Bonafe A, Budzik RF, Bhuva P, et al. DAWN trial investigators. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018 Jan;378:11-21. https://doi.org/10.1056/NEJMoa1706442
  • 12 Albers G, Marks M, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, et al. DEFUSE 3 Investigators. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018;378:708-18. https://doi.org/10.1056/NEJMoa1713973
  • 13 National Institute of Neurological Disorders and Stroke. NIH Stroke Scale. Available from: https://www.ninds.nih.gov/doctors/NIH Stroke Scale.pdf
  • 14 Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke. 2003;34(8):109-37. https://doi.org/10.1161/01.STR.0000082721.62796.09
  • 15 Goyal M, Menon BK, van Zwam WH, Dippel DJW, Mitchell PJ, Demchuk AM, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: A meta-analysis of individual patient data from five randomised trials. Lancet. 2016 Apr;387(10029):1723-31. https://doi.org/10.1016/S0140-6736(16)00163-X
  • 16 Ouriques Martins SC, Sacks C, Hacke W, Brainin M, de Assis Figueiredo F, Marques Pontes-Neto O, et al. Priorities to reduce the burden of stroke in Latin American countries. Lancet Neurol. 2019 Jul;18(7):674-83. https://doi.org/10.1016/S1474-4422(19)30068-7
  • 17 Nakiri G, Castro-Alfonso L, Monsignore L, Dias FA, Alessio-Alves FF, Fabio SR, et al. Experience on Mechanical Thrombectomy for Acute Stroke Treatment in a Brazilian University Hospital. J Stroke Cerebrovasc Dis. 2017;26(3):532-7. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.11.128
  • 18 Cabral N, Conforto A, Magalhaes P, Longo LL, Moro CHC, Appel H, et al. Intravenous rtPA versus mechanical thrombectomy in acute ischemic stroke: A historical cohort in Joinville, Brazil. eNeurologicalSci. 2016 Dec;5:1-6. https://doi.org/10.1016/j.ensci.2016.04.002
  • 19 Muñoz J, Rivillas J, González Jaramillo N. Trombectomía mecánica en pacientes con ataque cerebrovascular isquémico: serie de casos en un centro de referencia colombiano. Acta Neurol Colomb. 2017;33(2):68-73. http://dx.doi.org/10.22379/24224022136
  • 20 Colla Machado PE, Pigretti SG, Balian NR, Luzzi AA, Rabellino JM, Peralta OA, et al. Trombectomía mecánica en el tratamiento del accidente cerebrovascular isquémico: experiencia de un centro de alta complejidad en Argentina. Neurol Arg. 2016 Jul/Sep;8(3):145-51. https://doi.org/10.1016/j.neuarg.2016.02.011
  • 21 Pontes-Neto OM, Cougo P, Martins SC, Abud DG, Nogueira RG, Miranda M, et al. Brazilian guidelines for endovascular treatment of patients with acute ischemic stroke. Arq Neuropsiquiatr. 2017 Jan;75(1):50-6. http://dx.doi.org/10.1590/0004-282x20160174